IDXX Idexx Laboratories margins

Relative Growth: Rel. Growth: 87

Relative Strength: Rel. Strength: 31

Relative Valuation: Rel. Valuation: 25

Relative Profitability: Rel. Profitability: 94

Gross margin

62.4%

Operating margin

32%

EBITDA margin

35.5%

Net margin

25%

The Idexx Laboratories shows a gross margin of 62.4%, an operating margin of 32%, an EBITDA margin of 35.5%, and a net margin of 25%. All reported margins improved year over year, led by gross margin with an increase of 0.9 percentage points.

IDXX margin history

Gross, operating, EBITDA and net margin trends

Over the last 3 years, Idexx Laboratories's margins averaged 61.16% gross, 30.29% operating, 33.8% EBITDA, and 23.65% net. All four current margins are above their three-year averages.

IDXX margin expansion

Year-over-year margin changes in percentage points

Gross margin expanded by 0.9 percentage points, operating margin by 0.9 percentage points, EBITDA margin by 0.8 percentage points, and net margin by 0.6 percentage points, led by gross and operating margins with an increase of 0.9 percentage points.

Gross margin expansion

0.9pp

Operating margin expansion

0.9pp

EBITDA margin expansion

0.8pp

Net margin expansion

0.6pp

IDXX Gross margin

Idexx Laboratories's gross margin averaged 61.16% over the last 3 years. Compared with its three-year average, Idexx Laboratories's current gross margin is 62.4% and is 1.2 percentage points above its three-year average. Over the last 3 years, Idexx Laboratories's gross margin peaked at 62.4% in Jun 2026 and reached a low of 59.8% in Dec 2023.

IDXX Operating margin

Idexx Laboratories's operating margin averaged 30.29% over the last 3 years. Idexx Laboratories currently reports an operating margin of 32%, 1.7 percentage points above its three-year average. Over the last 3 years, Idexx Laboratories's operating margin peaked at 32% in Jun 2026 and reached a low of 28.6% in Jun 2024.

IDXX EBITDA margin

Throughout the last 3 years, Idexx Laboratories had an average EBITDA margin of 33.8%. Idexx Laboratories's current EBITDA margin is 35.5% and is 1.7 percentage points above its three-year average. Looking back over the last 3 years, Idexx Laboratories's EBITDA margin reached 35.5% at its highest point in Jun 2026 and 32.2% at its lowest in Jun 2024.

IDXX Net margin

Looking back over the last 3 years, Idexx Laboratories recorded an average net margin of 23.65%. Idexx Laboratories's current net margin is 25% and is 1.4 percentage points above its three-year average. The highest net margin for Idexx Laboratories was 25% in Jun 2026, while the lowest was 22.3% in Jun 2024.

IDXX margin group comparison

Margins compared with peer-group, industry and sector averages

Idexx Laboratories's gross margin of 62.4% is above the industry and its peers average but below the Healthcare sector average. In comparison with its Healthcare sector average of 68.4%, Idexx Laboratories's gross margin is 9% lower.

IDXX margin peer comparison

Compare margins with selected peers

Frequently asked questions

What is Idexx Laboratories's gross margin?

For the period ending Jun 30, 2026, IDXX recorded a gross margin of 62.4%.

What is Idexx Laboratories's operating margin?

For the period ending Jun 30, 2026, IDXX recorded an operating margin of 32%.

What is Idexx Laboratories's EBITDA margin?

For the period ending Jun 30, 2026, IDXX recorded an EBITDA margin of 35.5%.

What is Idexx Laboratories's net margin?

As of Jun 30, 2026, IDXX has a net margin of 25%.

What are the average margins of IDXX?

Idexx Laboratories's average margins over the last 3 years were 61.2% gross, 30.3% operating, 33.8% EBITDA, and 23.7% net.

What are the highest historical margins of IDXX?

Across the 5-year period, IDXX posted its highest margins at 62.4% gross in Jun 2026, 32% operating in Jun 2026, 35.5% EBITDA in Jun 2026, and 25% net in Jun 2026.

What are the lowest historical margins of IDXX?

Idexx Laboratories's lowest recorded margins during the past 5 years were 58.6% gross in Mar 2022, 25.8% operating in Jun 2022, 29.1% EBITDA in Jun 2022, and 20.1% net in Jun 2022.